BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18235152)

  • 1. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.
    Perianayagam A; Sterns RH; Silver SM; Grieff M; Mayo R; Hix J; Kouides R
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):331-6. PubMed ID: 18235152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in Severe Hyponatremia Treated With and Without Desmopressin.
    MacMillan TE; Cavalcanti RB
    Am J Med; 2018 Mar; 131(3):317.e1-317.e10. PubMed ID: 29061503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of desmopressin acetate in severe hyponatremia in the intensive care unit.
    Rafat C; Schortgen F; Gaudry S; Bertrand F; Miguel-Montanes R; Labbé V; Ricard JD; Hajage D; Dreyfuss D
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):229-37. PubMed ID: 24262506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline.
    Tran LK; Marino KK; DeGrado JR; Szumita PM; Dube KM
    Am J Med Sci; 2021 Jun; 361(6):711-717. PubMed ID: 33812910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin to Prevent Rapid Sodium Correction in Severe Hyponatremia: A Systematic Review.
    MacMillan TE; Tang T; Cavalcanti RB
    Am J Med; 2015 Dec; 128(12):1362.e15-24. PubMed ID: 26031887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
    Sood L; Sterns RH; Hix JK; Silver SM; Chen L
    Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
    Choi EY; Park JS; Kim YT; Park SY; Kim GH
    Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative Use of Desmopressin for Treatment of Profound Hyponatremia in the Setting of Emergency Surgery: A Case Report.
    Watterworth BS; Noorani RJ
    A A Pract; 2018 Jul; 11(2):54-56. PubMed ID: 29634545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Relowering of Serum Sodium Concentration Overcomes Disturbances in Consciousness during Hyponatremia Overcorrection and Prevents Osmotic Demyelination Syndrome.
    Ochiai H; Uenishi E
    Intern Med; 2018; 57(16):2353-2357. PubMed ID: 30111674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hyponatremia.
    Sterns RH; Hix JK; Silver S
    Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):493-8. PubMed ID: 20539224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDAVP to prevent rapid correction in hyponatremia.
    Goldszmidt MA; Iliescu EA
    Clin Nephrol; 2000 Mar; 53(3):226-9. PubMed ID: 10749304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of a Standardized Sodium Protocol on Incidence and Outcome of Dysnatremias in Neurocritical Care.
    Spatenkova V; Bradac O; Skrabalek P
    J Neurol Surg A Cent Eur Neurosurg; 2015 Jul; 76(4):279-90. PubMed ID: 25539069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
    Smego AR; Backeljauw P; Gutmark-Little I
    J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of intranasal desmopressin therapy with overcorrection of severe hyponatremia: A retrospective, propensity score-based, single-center cohort study.
    Jingushi N; Tsuzuki S; Fujii K; Uenishi N; Iwata M; Terasawa T
    J Crit Care; 2021 Aug; 64():53-61. PubMed ID: 33794467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
    Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
    Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series.
    Achinger SG; Arieff AI; Kalantar-Zadeh K; Ayus JC
    Nephrol Dial Transplant; 2014 Dec; 29(12):2310-5. PubMed ID: 25107337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing overcorrection of hyponatraemia with desmopressin.
    Tomlin SC; Williams R; Riley S
    BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Desmopressin in the Management of Severe, Hypovolemic Hyponatremia: A Single-Center, Comparative Analysis.
    Ward FL; Tobe SW; Naimark DMJ
    Can J Kidney Health Dis; 2018; 5():2054358118761051. PubMed ID: 29593879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation and Validation of a Novel Risk Score to Predict Overcorrection of Severe Hyponatremia: The Severe Hyponatremia Overcorrection Risk (SHOR) Score.
    Woodfine JD; Sood MM; MacMillan TE; Cavalcanti RB; van Walraven C
    Clin J Am Soc Nephrol; 2019 Jul; 14(7):975-982. PubMed ID: 31189541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes Insipidus and Syndrome of Inappropriate Antidiuretic Hormone in Critically Ill Patients.
    Harrois A; Anstey JR
    Crit Care Clin; 2019 Apr; 35(2):187-200. PubMed ID: 30784603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.